Welcome to our dedicated page for Electromed news (Ticker: ELMD), a resource for investors and traders seeking the latest updates and insights on Electromed stock.
Electromed, Inc. (NYSE American: ELMD) is a medical device company that develops, manufactures, and sells airway clearance therapy products, including the SmartVest® Airway Clearance System, for patients with compromised pulmonary function. Company news often highlights its role as a leader in airway clearance technologies and its focus on High Frequency Chest Wall Oscillation (HFCWO) therapy, particularly in the homecare setting.
Newsflow for Electromed frequently centers on financial results, such as quarterly and annual earnings releases that detail net revenues, operating income, net income, and segment performance in direct homecare and non-homecare markets. These announcements often discuss trends in referrals and approvals, sales force expansion, and gross margin dynamics, as well as commentary from management on operational execution and efficiency initiatives.
Investors can also expect corporate and capital markets updates, including announcements about share repurchase authorizations approved by the board of directors and index-related milestones, such as Electromed’s addition to the Russell 2000® and Russell 3000® indexes. The company issues press releases when it schedules earnings conference calls and webcasts, providing dial-in details and replay information.
Another recurring category of news involves investor conference participation. Electromed regularly announces its presence at events hosted by organizations such as Noble Capital Markets, LD Micro, Canaccord Genuity, and Investor Summit, where management presents the company’s airway clearance business and growth strategy to institutional and other investors.
For readers tracking ELMD, this news page provides a centralized view of Electromed’s earnings announcements, capital allocation decisions, index inclusions, and investor outreach activities, offering context on how the company is executing its strategy in the airway clearance therapy market.
Electromed, Inc. (NYSE American: ELMD) is set to release its fiscal 2021 third quarter financial results on May 11, 2021, after market close. The company will host a conference call at 5:00 p.m. Eastern Time to discuss these results. Interested participants can join by calling (877) 407-9753 for domestic calls and (201) 493-6739 for international calls. A live webcast will be accessible via Electromed’s Investor Relations website, and a replay will also be available online post-event.
Electromed, Inc. (NYSE American: ELMD) announced that Kathleen Skarvan, President and CEO, and Mike MacCourt, CFO, will participate in the Sidoti Spring 2021 Virtual Investor Conference on March 24-25, 2021. They will be available for one-on-one meetings during both days. Electromed specializes in airway clearance technology, manufacturing products like the SmartVest® Airway Clearance System, aiding patients with impaired pulmonary function. The group presentation is scheduled for March 24, 2021, at 2:30 PM Eastern Time. Further details can be found on their website.
Electromed (NYSE American: ELMD) reported a 11.1% increase in net revenue, reaching $9.5 million for Q2 FY 2021, driven by a 16.1% rise in home care revenue to $8.9 million. Gross profit margin improved to 79.2%, up from 78.1% in Q2 FY 2020. Net income remained stable at $1.2 million, translating to $0.13 per diluted share. Despite a 37.4% decline in institutional revenue due to COVID-19's impact, the company maintains a robust cash position of $11.7 million. Management expresses cautious optimism for continued growth in the latter half of FY 2021.
Electromed, Inc. (NYSE American: ELMD) will release its fiscal 2021 second quarter financial results on February 9, 2021, after market close. A conference call will follow at 5:00 p.m. ET to discuss the results. Interested participants can join via phone, with domestic and international numbers provided. The call will also be accessible through a live webcast in the Investor Relations section of Electromed's website. The company manufactures airway clearance products, including the SmartVest Airway Clearance System.